title: Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma.
authors.affiliation: Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
authors.forename: F V
authors.initials: FV
authors.lastname: Fossella
authors.forename: R J
authors.initials: RJ
authors.lastname: Winn
authors.forename: P Y
authors.initials: PY
authors.lastname: Holoye
authors.forename: M N
authors.initials: MN
authors.lastname: Raber
authors.forename: L
authors.initials: L
authors.lastname: Holden
authors.forename: R
authors.initials: R
authors.lastname: Belt
authors.forename: H
authors.initials: H
authors.lastname: Allen
authors.forename: B
authors.initials: B
authors.lastname: Hallinan
authors.forename: K
authors.initials: K
authors.lastname: Harper
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000556:secondary; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013866:Thioguanine / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D013866:Thioguanine